CALEB HUFFMAN: Open Payments
NPI 1265108393 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 74 payments from 22 companies in 2025. Trend: 2023 $941 · 2024 $2,081 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $497 |
| Janssen Biotech, Inc. | 7 | $257 |
| AstraZeneca Pharmaceuticals LP | 5 | $173 |
| PFIZER INC. | 5 | $112 |
| Janssen Scientific Affairs, LLC | 1 | $103 |
| ABBVIE INC. | 3 | $72 |
| UCB, Inc. | 3 | $59 |
| Radius Health, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
Products named: TREMFYA, OTEZLA, SAPHNELO, XELJANZ, SKYRIZI, KRYSTEXXA, TAVNEOS, EVENITY.
Industry payments across NC — which companies pay providers there.
